Advertisement
Screener

REPLIGEN CORP (RGEN) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

REPLIGEN CORP Amortization of Intangible Assets

REPLIGEN CORP (RGEN) reported Amortization of Intangible Assets of $9.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-29

  • REPLIGEN CORP amortization of intangible assets for the quarter ending 2026-06-30 was $9.50M, a 7.77% decline year-over-year.
  • REPLIGEN CORP amortization of intangible assets for the quarter ending 2026-03-31 was $9.80M, a 7.69% increase year-over-year.
  • REPLIGEN CORP amortization of intangible assets for the quarter ending 2025-12-31 was $9.80M, a 12.64% increase year-over-year.
  • REPLIGEN CORP amortization of intangible assets for the quarter ending 2025-09-30 was $9.90M, a 15.12% increase year-over-year.
  • REPLIGEN CORP amortization of intangible assets for fiscal 2025 was $39.10M, a 12.68% increase from fiscal 2024.
  • REPLIGEN CORP amortization of intangible assets for fiscal 2024 was $34.70M, a 9.81% increase from fiscal 2023.
  • REPLIGEN CORP amortization of intangible assets for fiscal 2023 was $31.60M, a 16.61% increase from fiscal 2022.
  • REPLIGEN CORP amortization of intangible assets for fiscal 2022 was $27.10M, a 22.62% increase from fiscal 2021.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 3 month as first filedAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 6 month as first filedAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 9 month as first filedAmortization of Intangible Assets 12 monthAmortization of Intangible Assets 12 month as first filed
2026-06-30$9.50M
10-Q · filed 2026-07-29
$19.30M
10-Q · filed 2026-07-29
$29.10M
derived: sum of 3 quarters · filed 2026-07-29
$39.00M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$9.80M
10-Q · filed 2026-05-06
$19.60M
derived: sum of 2 quarters · filed 2026-05-06
$29.50M
derived: sum of 3 quarters · filed 2026-05-06
$39.80M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$9.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$19.70M
derived: sum of 2 quarters · filed 2026-02-26
$30.00M
derived: sum of 3 quarters · filed 2026-07-29
$39.10M
10-K · filed 2026-02-26
2025-09-30$9.90M
10-Q · filed 2025-11-04
$20.20M
derived: sum of 2 quarters · filed 2026-07-29
$29.30M
10-Q · filed 2025-11-04
$38.00M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$10.30M
10-Q · filed 2026-07-29
$19.40M
10-Q · filed 2026-07-29
$28.10M
derived: sum of 3 quarters · filed 2026-07-29
$36.70M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$9.10M
10-Q · filed 2026-05-06
$17.80M
derived: sum of 2 quarters · filed 2026-05-06
$26.40M
derived: sum of 3 quarters · filed 2026-05-06
$35.10M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$8.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$17.30M
derived: sum of 2 quarters · filed 2026-02-26
$26.00M
derived: sum of 3 quarters · filed 2026-02-26
$34.70M
10-K · filed 2026-02-26
2024-09-30$8.60M
10-Q · filed 2025-11-04
$17.30M
derived: sum of 2 quarters · filed 2025-11-04
$26.00M
10-Q · filed 2025-11-04
$34.80M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$8.70M
10-Q · filed 2025-08-07
$8.50M
10-Q · filed 2024-07-30
$17.40M
10-Q · filed 2025-08-07
$17.20M
10-Q · filed 2024-07-30
$26.20M
derived: sum of 3 quarters · filed 2026-02-26
$33.80M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$8.70M
10-Q · filed 2025-04-29
$8.60M
10-Q · filed 2024-05-01
$17.50M
derived: sum of 2 quarters · filed 2026-02-26
$25.10M
derived: sum of 3 quarters · filed 2026-02-26
$32.80M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$8.80M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26
$16.40M
derived: sum of 2 quarters · filed 2026-02-26
$24.10M
derived: sum of 3 quarters · filed 2026-02-26
$31.60M
10-K · filed 2026-02-26
$31.10M
10-K · filed 2024-02-22
2023-09-30$7.60M
10-Q/A · filed 2024-11-18
$7.50M
10-Q · filed 2023-10-31
$15.30M
derived: sum of 2 quarters · filed 2024-11-18
$22.80M
10-Q/A · filed 2024-11-18
$22.40M
10-Q · filed 2023-10-31
$30.10M
derived: sum of 4 quarters · filed 2025-03-14
2023-06-30$7.70M
10-Q/A · filed 2024-11-18
$7.50M
10-Q · filed 2023-08-02
$15.10M
10-Q/A · filed 2024-11-18
$14.90M
10-Q · filed 2023-08-02
$22.50M
derived: sum of 3 quarters · filed 2025-03-14
$29.10M
derived: sum of 4 quarters · filed 2025-03-14
2023-03-31$7.50M
10-Q/A · filed 2024-11-18
$7.40M
10-Q · filed 2023-05-02
$14.80M
derived: sum of 2 quarters · filed 2025-03-14
$21.40M
derived: sum of 3 quarters · filed 2025-03-14
$28.00M
derived: sum of 4 quarters · filed 2025-03-14
2022-12-31$7.30M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14
$13.90M
derived: sum of 2 quarters · filed 2025-03-14
$20.50M
derived: sum of 3 quarters · filed 2025-03-14
$27.10M
10-K · filed 2025-03-14
2022-09-30$6.60M
10-Q/A · filed 2024-11-18
$13.20M
derived: sum of 2 quarters · filed 2024-11-18
$19.80M
10-Q/A · filed 2024-11-18
$25.80M
derived: sum of 4 quarters · filed 2024-11-18
2022-06-30$6.60M
10-Q/A · filed 2024-11-18
$13.20M
10-Q/A · filed 2024-11-18
$19.20M
derived: sum of 3 quarters · filed 2024-11-18
$24.90M
derived: sum of 4 quarters · filed 2024-11-18
2022-03-31$6.60M
10-Q/A · filed 2024-11-18
$12.60M
derived: sum of 2 quarters · filed 2024-11-18
$18.30M
derived: sum of 3 quarters · filed 2024-11-18
$23.50M
derived: sum of 4 quarters · filed 2024-11-18
2021-12-31$6.00M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18
$11.70M
derived: sum of 2 quarters · filed 2024-11-18
$16.90M
derived: sum of 3 quarters · filed 2024-11-18
$22.10M
10-K/A · filed 2024-11-18
2021-09-30$5.70M
10-Q · filed 2022-11-01
$10.90M
derived: sum of 2 quarters · filed 2022-11-01
$16.10M
10-Q · filed 2022-11-01
$20.40M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$5.20M
10-Q · filed 2022-08-02
$10.40M
10-Q · filed 2022-08-02
$14.70M
derived: sum of 3 quarters · filed 2023-02-22
$18.70M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$5.20M
10-Q · filed 2022-04-27
$9.50M
derived: sum of 2 quarters · filed 2023-02-22
$13.50M
derived: sum of 3 quarters · filed 2023-02-22
$17.40M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$4.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$8.30M
derived: sum of 2 quarters · filed 2023-02-22
$12.20M
derived: sum of 3 quarters · filed 2023-02-22
$16.10M
10-K · filed 2023-02-22
2020-09-30$4.00M
10-Q · filed 2021-10-28
$7.90M
derived: sum of 2 quarters · filed 2021-10-28
$11.80M
10-Q · filed 2021-10-28
$15.80M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-30$3.90M
10-Q · filed 2021-07-27
$7.80M
10-Q · filed 2021-07-27
$11.80M
derived: sum of 3 quarters · filed 2022-02-17
$15.70M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-31$3.90M
10-Q · filed 2021-05-04
$7.90M
derived: sum of 2 quarters · filed 2022-02-17
$11.80M
derived: sum of 3 quarters · filed 2022-02-17
$14.90M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
$7.90M
derived: sum of 2 quarters · filed 2022-02-17
$11.00M
derived: sum of 3 quarters · filed 2022-02-17
$13.60M
10-K · filed 2022-02-17
2019-09-30$3.90M
10-Q · filed 2020-11-05
$7.00M
derived: sum of 2 quarters · filed 2020-11-05
$9.60M
10-Q · filed 2020-11-05
$12.30M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$3.10M
10-Q · filed 2020-07-30
$5.70M
10-Q · filed 2020-07-30
$8.40M
derived: sum of 3 quarters · filed 2021-02-24
$11.00M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$2.60M
10-Q · filed 2020-05-06
$5.30M
derived: sum of 2 quarters · filed 2021-02-24
$7.90M
derived: sum of 3 quarters · filed 2021-02-24
$10.50M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$2.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$5.30M
derived: sum of 2 quarters · filed 2021-02-24
$7.90M
derived: sum of 3 quarters · filed 2021-02-24
$10.60M
10-K · filed 2021-02-24
2018-09-30$2.60M
10-Q · filed 2019-10-31
$5.20M
derived: sum of 2 quarters · filed 2019-10-31
$7.90M
10-Q · filed 2019-10-31
$7.91M
10-Q · filed 2018-11-01
$10.62M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$2.60M
10-Q · filed 2019-08-01
$5.30M
10-Q · filed 2019-08-01
$5.30M
10-Q · filed 2018-08-02
$8.02M
derived: sum of 3 quarters · filed 2020-02-26
$10.02M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$2.70M
10-Q · filed 2019-05-09
$2.66M
10-Q · filed 2018-05-08
$5.42M
derived: sum of 2 quarters · filed 2020-02-26
$7.42M
derived: sum of 3 quarters · filed 2020-02-26
$8.19M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$2.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$4.72M
derived: sum of 2 quarters · filed 2020-02-26
$5.49M
derived: sum of 3 quarters · filed 2020-02-26
$6.20M
10-K · filed 2020-02-26
$6.21M
10-K · filed 2018-02-22
2017-09-30$1.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$2.76M
derived: sum of 2 quarters · filed 2018-11-01
$3.48M
10-Q · filed 2018-11-01
$4.09M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$769.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$1.48M
10-Q · filed 2018-08-02
$2.10M
derived: sum of 3 quarters · filed 2019-03-01
$2.65M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$715.00K
10-Q · filed 2018-05-08
$1.33M
derived: sum of 2 quarters · filed 2019-03-01
$1.88M
derived: sum of 3 quarters · filed 2019-03-01
$2.42M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31$616.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$1.17M
derived: sum of 2 quarters · filed 2019-03-01
$1.70M
derived: sum of 3 quarters · filed 2019-03-01
$2.10M
10-K · filed 2019-03-01
$2.05M
10-K · filed 2017-02-23
2016-09-30$552.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$1.08M
derived: sum of 2 quarters · filed 2017-11-09
$1.48M
10-Q · filed 2017-11-09
$1.88M
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30$533.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$932.00K
10-Q · filed 2017-08-03
$1.33M
derived: sum of 3 quarters · filed 2018-02-22
$1.73M
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31$399.00K
10-Q · filed 2017-05-04
$798.00K
derived: sum of 2 quarters · filed 2018-02-22
$1.20M
derived: sum of 3 quarters · filed 2018-02-22
$1.60M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$399.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$799.00K
derived: sum of 2 quarters · filed 2018-02-22
$1.20M
derived: sum of 3 quarters · filed 2018-02-22
$1.60M
10-K · filed 2018-02-22
2015-09-30$400.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$800.00K
derived: sum of 2 quarters · filed 2016-11-03
$1.20M
10-Q · filed 2016-11-03
$1.62M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30$400.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$801.00K
10-Q · filed 2016-08-04
$1.22M
derived: sum of 3 quarters · filed 2017-02-23
$1.66M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31$401.00K
10-Q · filed 2016-05-05
$822.00K
derived: sum of 2 quarters · filed 2017-02-23
$1.26M
derived: sum of 3 quarters · filed 2017-02-23
$1.58M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$421.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$855.00K
derived: sum of 2 quarters · filed 2017-02-23
$1.18M
derived: sum of 3 quarters · filed 2017-02-23
$1.43M
10-K · filed 2017-02-23
2014-09-30$434.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$756.00K
derived: sum of 2 quarters · filed 2014-11-07
$1.00M
10-Q · filed 2014-11-07
$1.25M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$322.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$570.00K
10-Q · filed 2014-08-11
$815.00K
derived: sum of 3 quarters · filed 2016-02-25
$1.12M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$248.00K
10-Q · filed 2014-05-09
$493.00K
derived: sum of 2 quarters · filed 2016-02-25
$801.00K
derived: sum of 3 quarters · filed 2016-02-25
$1.02M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$245.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$553.00K
derived: sum of 2 quarters · filed 2016-02-25
$771.00K
derived: sum of 3 quarters · filed 2016-02-25
$1.02M
10-K · filed 2016-02-25
2013-09-30$308.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$526.00K
derived: sum of 2 quarters · filed 2013-11-08
$777.00K
10-Q · filed 2013-11-08
$1.04M
derived: sum of 4 quarters · filed 2015-03-17
2013-06-30$218.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
$469.00K
10-Q · filed 2013-08-07
$729.00K
derived: sum of 3 quarters · filed 2015-03-17
$1.01M
derived: sum of 4 quarters · filed 2015-03-17
2013-03-31$251.00K
10-Q · filed 2013-05-07
$511.00K
derived: sum of 2 quarters · filed 2015-03-17
$793.00K
derived: sum of 3 quarters · filed 2015-03-17
2012-12-31$260.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17
$542.00K
derived: sum of 2 quarters · filed 2015-03-17
$1.02M
10-K · filed 2015-03-17
2012-09-30$282.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$757.00K
10-Q · filed 2012-11-08
2012-06-30$475.00K
10-Q · filed 2012-08-09
2011-12-31$158.00K
10-K · filed 2014-03-14
$179.00K
10-K · filed 2013-03-15
2010-12-31$134.00K
10-K · filed 2014-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78